This study is in progress, not accepting new patients
Transthyretin Amyloidosis Outcome Survey (THAOS)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT00628745
- Study Type
- Observational
- Participants
- About 6224 people participating
- Last Updated